AHA says penalties as well as incentives are needed to face down ‘persistent’ drug shortages 글 내용 전체보기
Sen. Schumer curiously links Shingrix shortage to shutdown, but Glaxo says there’s no connection 글 내용 전체보기
Congressmen to regulators: BMS-Celgene merger will stifle competition and raise drug prices 글 내용 전체보기
